Skip to main content

Advertisement

Log in

Functional loss in daily activity in ovarian cancer patients undergoing chemotherapy

  • Gynecologic Oncology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

Cancer survivors frequently experience cancer or treatment-related symptoms and functional morbidities that can be addressed through rehabilitation services, but these symptoms often go unnoticed and seldom managed. This study seeks to investigate the undetected patient symptoms and functional loss related to the activities of daily living (ADLs) in ovarian cancer patients during chemotherapy and to identify the influence of chemotherapy on such loss.

Methods

Ovarian cancer patients undergoing chemotherapy were identified from June to August 2016, who were treated at the department of Gynecology and Obstetrics of two tertiary hospitals. The questionnaires on the present cancer and treatment-related symptoms, patient recognition of rehabilitation needs, and the Katz index score were collected.

Results

Records of total 168 ovarian cancer patients were selected and reviewed. The majority of patients (93.5%) experienced at least one symptom, with paresthesia (76.2%), fatigue (63.1%), pain, muscle weakness, memory and concentration dysfunction, lymphedema, breathing discomfort, dysphagia, and speech difficulty being the primary complaints in descending order. About 20% of ovarian cancer patients under chemotherapy had functional dependence in ADLs. The most affected ADL functions were continence, bathing, transfer, and dressing in descending order. Fatigue symptom and the functional dependence showed a significant correlation in proportion to the total number of chemotherapy cycles.

Conclusions

There are undetected symptoms and functional loss in ovarian cancer patients during chemotherapy, which aggravated in relation to the increase in accumulated chemotherapy. Timely and appropriate rehabilitative intervention may help minimize these symptoms and functional loss, and further contribute to the improved quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Gilbert SM, Miller DC, Hollenbeck BK, Montie JE, Wei JT (2008) Cancer survivorship: challenges and changing paradigms. J Urol 179:431–438

    Article  PubMed  PubMed Central  Google Scholar 

  2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386

    Article  CAS  Google Scholar 

  3. Sun CC, Bodurka DC, Weaver CB, Rasu R, Wolf JK, Bevers MW, Smith JA, Wharton JT, Rubenstein EB (2005) Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer. Support Care Cancer 13:219–227

    Article  PubMed  Google Scholar 

  4. Mardas M, Jamka M, Madry R, Walkowiak J, Krotkopad M, Stelmach-Mardas M (2015) Dietary habits changes and quality of life in patients undergoing chemotherapy for epithelial ovarian cancer. Support Care Cancer 23:1015–1023

    Article  PubMed  Google Scholar 

  5. Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvao DA, Pinto BM, Irwin ML, Wolin KY, Segal RJ, Lucia A, Schneider CM, von Gruenigen VE, Schwartz AL, American College of Sports M (2010) American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42:1409–1426

    Article  PubMed  Google Scholar 

  6. Bodurka-Bevers D, Basen-Engquist K, Carmack CL, Fitzgerald MA, Wolf JK, de Moor C, Gershenson DM (2000) Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Gynecol Oncol 78:302–308

    Article  CAS  PubMed  Google Scholar 

  7. Carlson LE, Waller A, Mitchell AJ (2012) Screening for distress and unmet needs in patients with cancer: review and recommendations. J Clin Oncol 30:1160–1177

    Article  PubMed  Google Scholar 

  8. Cheville AL, Alberts SR, Rummans TA, Basford JR, Lapid MI, Sloan JA, Satele DV, Clark MM (2015) Improving adherence to cancer treatment by addressing quality of life in patients with advanced gastrointestinal cancers. J Pain Symptom Manag 50:321–327

    Article  PubMed  PubMed Central  Google Scholar 

  9. Cheville AL, Kornblith AB, Basford JR (2011) An examination of the causes for the underutilization of rehabilitation services among people with advanced cancer. Am J Phys Med Rehabil 90:S27–S37

    Article  PubMed  Google Scholar 

  10. Stout NL, Silver JK, Raj VS, Rowland J, Gerber L, Cheville A, Ness KK, Radomski M, Nitkin R, Stubblefield MD, Morris GS, Acevedo A, Brandon Z, Braveman B, Cunningham S, Gilchrist L, Jones L, Padgett L, Wolf T, Winters-Stone K, Campbell G, Hendricks J, Perkin K, Chan L (2016) Toward a national initiative in cancer rehabilitation: recommendations from a subject matter expert group. Arch Phys Med Rehabil 97:2006–2015

    Article  PubMed  Google Scholar 

  11. Farthmann J, Hanjalic-Beck A, Veit J, Rautenberg B, Stickeler E, Erbes T, Foldi M, Hasenburg A (2016) The impact of chemotherapy for breast cancer on sexual function and health-related quality of life. Support Care Cancer 24:2603–2609

    Article  PubMed  Google Scholar 

  12. Eichler M, Singer S, Janni W, Harbeck N, Rack B, Augustin D, Wischnik A, Kiechle M, Ettl J, Scholz C, Fink V, Schwentner L (2017) Pretreatment quality of life, performance status and their relation to treatment discontinuation and treatment changes in high-risk breast cancer patients receiving chemotherapy: results from the prospective randomized ADEBAR trial. Breast Cancer 24:319–325

    Article  PubMed  Google Scholar 

  13. Jo JM, Hwang JH, Lee CH, Kang HJ, Yu JN (2010) The need of cancer patients for rehabilitation services. J Korean Acad Rehab Med 34:691–700

    Google Scholar 

  14. Lindgren A, Dunberger G, Enblom A (2017) Experiences of incontinence and pelvic floor muscle training after gynaecologic cancer treatment. Support Care Cancer 25:157–166

    Article  PubMed  Google Scholar 

  15. Macquart-Moulin G, Viens P, Genre D, Bouscary ML, Resbeut M, Gravis G, Camerlo J, Maraninchi D, Moatti JP (1999) Concomitant chemoradiotherapy for patients with nonmetastatic breast carcinoma: side effects, quality of life, and organization. Cancer 85:2190–2199

    Article  CAS  PubMed  Google Scholar 

  16. Curt GA, Breitbart W, Cella D, Groopman JE, Horning SJ, Itri LM, Johnson DH, Miaskowski C, Scherr SL, Portenoy RK, Vogelzang NJ (2000) Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 5:353–360

    Article  CAS  PubMed  Google Scholar 

  17. Bhugwandass CS, Pijnenborg JM, Pijlman B, Ezendam NP (2016) Effect of chemotherapy on health-related quality of life among early-stage ovarian cancer survivors: a study from the population-based PROFILES registry. Curr Oncol 23:e556–e562

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Ferretti-Rebustini RE, Balbinotti MA, Jacob-Filho W, Rebustini F, Suemoto CK, Pasqualucci CA, Farfel JM, Leite RE, Grinberg LT, Nitrini R (2015) Validity of the Katz Index to assess activities of daily living by informants in neuropathological studies. Rev Esc Enferm USP 49:946–952

    Article  PubMed  Google Scholar 

  19. Lakusta CM, Atkinson MJ, Robinson JW, Nation J, Taenzer PA, Campo MG (2001) Quality of life in ovarian cancer patients receiving chemotherapy. Gynecol Oncol 81:490–495

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

IYCheong: project development, data analysis, manuscript writing. JSY: data collection, data analysis. SHC: data collection. SYP: data collection. H-JS: data collection, management. J-WL: data collection. JHH (corresponding author): protocol development, manuscript editing.

Corresponding author

Correspondence to Ji Hye Hwang.

Ethics declarations

Conflict of interest

None. I have full control of all primary data and I agree to allow the journal to review the data if requested.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cheong, I.Y., Yoo, J.S., Chung, S.H. et al. Functional loss in daily activity in ovarian cancer patients undergoing chemotherapy. Arch Gynecol Obstet 299, 1063–1069 (2019). https://doi.org/10.1007/s00404-018-4996-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-018-4996-x

Keywords

Navigation